Sarcoma Topic Center: Cancer Management

Article

 

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The safety profile of teclistamab-based therapy in the MajesTEC-5 trial was expected based on the known compounds employed in each combination.
It may be critical to sequence BCL-2 inhibitors with BTK inhibitors for patients with mantle cell lymphoma in the relapsed/refractory setting.